In several recent studies it has been highlighted, that the early beginning of treatment is of great importance for the prevention of abnormal scarring. [2–7]

Stratamed is a breakthrough treatment that can be used on non epithelialized wounds and compromised skin, immediately following surgical procedures, skin resurfacing, trauma, burns* and radiation therapy. Stratamed leads to a faster re-epithelialization of the damaged skin [1] and dramatically decreases the incidence of abnormal scarring [2].

Early application – better scar outcome.

Stratamed creates an optimal environment for the healing process of the skin, which leads to faster wound healing, reduction in the inflammatory response and reduced symptomatic effects like redness/discoloration, itching, discomfort and pain [1].

Stratamed enables an effective wound healing, [1] enhances therapeutic results [1] and leads to the best possible scar outcome.

With high safety, efficacy and ease of use as well as an increased number of procedures where it can be used, Stratamed raises the bar for industry-leading silicone-based scar treatments.

1. Data on file. Stratpharma AG; Practice Dr. Sandhofer, Linz/Austria 2010
2. Gauglitz GG et al. Mol Med 2011;17(1–2):113–125
3. Upton Z et al. Wounds Int 2011; 2(1): 7–8
4. Tandara AA et al. Plast Reconstr Surg 2008; 61:1219–1225
5. Mustoe TA et al. Plast Reconstr Surg 2002; 110:560–571
6. Gold MH et al. Dermatol Surg 2001; 27:641–644
7. English RS et al. Dermatol Surg 1999; 25:631–638

* First and second degree burns, third degree burns only after the presence of granulating tissue